Introduction: The transmission of occult hepatitis B Virus (HBV) is a significant public health issue among transfused sickle cell disease (SCD) patients. Object: The aim of this study was to determine the prevalence of occult hepatitis B in SCD patients and to establish the association between HBsAg and anti HBc, according to the number of blood transfusions received. Patients and Methods: This epidemiological, descriptive and analytical study was conducted in three sickle cell care centers in Kinshasa from January to June 2018, involving 384 transfused SCD patients. Results: The study revealed that the age group 10 - 20 years was the most represented with a predominance of males (male-female sex ratio of 1.07). 65 patients of the study population tested positive for anti-HBc but negative for HbsAg and had occult hepatitis, representing 19.0 % of the total. Conclusion: Occult hepatitis B is a particular form of HBV infection that is increasingly attracting the attention of clinicians in the SCD patients.
References
[1]
Piel, F.B., Patil, A.P., Howes, R.E., Nyangiri, O.A., Gething, P.W., Dewi, M., et al. (2013) Global Epidemiology of Sickle Haemo-globin in Neonates: A Contemporary Geostatistical Model-Based Map and Population Estimates. The Lancet, 381, 142-151. https://doi.org/10.1016/s0140-6736(12)61229-x
[2]
WHO (2006) Secretariat Report on Sickle Cell Disease 59th World Health.
[3]
Makuwa, M., Bakouetela, J., Bassindikila, A., et al. (1996) Etude des marqueurs sérologiques de l’hépatite B chez les patients congolais testés pour l’infection à VIH. Médecine d’Afrique Noire, 43, 198-200.
[4]
PNLCD (2012) Programme National de Lutte Contre la Drépanocytose: Politique sectorielle de lutte contre la drépanocytose en RD Congo.
[5]
Kodondi, S.D., Kimboko, J.M., Kabakele, D.M.M., Bokolo, M.W., Tongu, E.N., Kangite, G.Y., et al. (2023) Expe-rience of Transfusion Exchanges at the Center for Mixed Medicine and SS Anemia; Kinshasa, Democratic Republic of the Congo. Open Access Library, 10, 1-12. https://doi.org/10.4236/oalib.1110015
[6]
Hoofnagle, J.H., Seeff, L.B., Bales, Z.B. and Zimmerman, H.J. (1978) Type B Hepatitis after Transfusion with Blood Containing Antibody to Hepatitis B Core Antigen. New England Journal of Medicine, 298, 1379-1383. https://doi.org/10.1056/nejm197806222982502
[7]
Tabor, E., Hoofnagle, J.H., Smallwood, L.A., Drucker, J.A., Pineda-Tamondong, G.C., Ni, L.Y., et al. (1979) Studies of Donors Who Transmit Posttransfusion Hepatitis. Transfusion, 19, 725-731. https://doi.org/10.1046/j.1537-2995.1979.19680104098.x
[8]
Mpesi, J.K. and Ngindu, M.A. (2017) Drépanocytose: Généralités, Enjeux, défis et perspectives d’avenir. Annales africaines de médecine, 11, Article 2017.
[9]
Seo, D.H. (2015) Occult Hepatitis B Virus Infection and Blood Transfusion. World Journal of Hepatology, 7, 600-606. https://doi.org/10.4254/wjh.v7.i3.600
[10]
Kengne, M., Onomo Medja, Y.F., Tedom, and Nwobegahay, J.M. (2021) Risque résiduel de la transmission par transfusion de l’infection du virus de l’hépatite B dû aux donneurs porteurs de l’infection du virus de l’hépatite B occulte à Yaoundé, Cameroun. Pan African Medical Journal, 39, Article 175. https://doi.org/10.11604/pamj.2021.39.175.22365
[11]
Ayed, Z., Houinato, D., Hocine, M., et al. (1995) Prévalence des marqueurs sériques des virus des hépatites B et C chez les donneurs de sang et les femmes enceintes en Algérie. Bulletin de la Societe de Pathologie Exotique, 88, 225-228.
[12]
Kissou, S.A., Koura, M., Sawadogo A., et al. (2017) étude des marqueurs sérologiques des hépatites virales B et C chez les drépanocytaires suivis en pédiatrie au CHU de Bobo-Dioulasso (Burkina Faso). Bulletin de la Société de Pathologie Exotique, 110, 160-164. https://doi.org/10.1007/s13149-017-0555-4
[13]
Oluyinka, O.O., Tong, H.V., Bui, T., Fagbami, A.H., Adekanle, O., Oju-rongbe, O. and Huong, V.T. (2015) Prevalence of Occult Hepatitis B Virus Infection in Blood Donors in Nigeria. Journal of Medical Virology, 87, 600-606.
[14]
Kramvis, A. and Kew, M.C. (2007) Epidemiology of Hepatitis B Virus in Africa, Its Genotypes and Clinical Associations of Genotypes. Hepatology Research, 37, S9-S19. https://doi.org/10.1111/j.1872-034x.2007.00098.x
[15]
Hutin, Y.J., Bulterys, M. and Hirnschall, G.O. (2020) How Far Are We from Viral Hepatitis Elimination Service Coverage Targets? Journal of the International AIDS Society, 21, e25050
[16]
Ware, R.E., de Montalembert, M., Tshilolo, L. and Abboud, M.R. (2017) Sickle cell disease. The Lancet, 390, 311-323. https://doi.org/10.1016/s0140-6736(17)30193-9
[17]
Bartolucci, P. (2014) Aspects épidémiologiques des maladies de l’hémoglobine. Dossier Maladies de l’hémoglobine, La Revue du Praticien, 64, 1108-1109.
[18]
Quinn, C.T., Rogers, Z.R., McCavit, T.L. and Buchanan, G.R. (2010) Improved Survival of Children and Adolescents with Sickle Cell Dis-ease. Blood, 115, 3447-3452. https://doi.org/10.1182/blood-2009-07-233700
[19]
Ware, R.E. and Aygun, B. (2009) Advances in the Use of Hydroxyurea. Hematology, 2009, 62-69. https://doi.org/10.1182/asheducation-2009.1.62
[20]
Walters, M.C., Hardy, K., Edwards, S., Adamkiewicz, T., Barkovich, J., Bernaudin, F., et al. (2010) Pulmonary, Gonadal, and Central Nervous System Status after Bone Marrow Transplantation for Sickle Cell Disease. Biology of Blood and Marrow Transplantation, 16, 263-272. https://doi.org/10.1016/j.bbmt.2009.10.005
[21]
Lebensburger, J.D., Howard, T.H., Hu, Z., et al. (2018) Hydroxyurea Therapy of a Pediatric Cohort with Sickle Cell Disease: Improved Survival and Decreased Hospitalization. American Journal of Hematology, 93, 943-948.
[22]
Shaker, O., Ahmed, A., Abdel Satar, I., El Ahl, H., Shousha, W. and Doss, W. (2011) Oc-cult Hepatitis B in Egyptian Thalassemic Children. The Journal of Infection in Developing Countries, 6, 340-346. https://doi.org/10.3855/jidc.1706
[23]
Mphahlele, M., Lukhwareni, A., Burnett, R., Moropeng, L. and Ngobeni, J. (2006) High Risk of Occult Hepatitis B Virus Infection in HIV-Positive Patients from South Africa. Journal of Clinical Virology, 35, 14-20. https://doi.org/10.1016/j.jcv.2005.04.003
[24]
Gwamzhi, L., Okwori, A., Agabi, Y. and Agwale, S. (2009) High Prevalence of Occult hepatitis B Virus among Patients with Chronic Hepatitis C Virus Infection in Jos, Nigeria. Journal of Medical Virology, 81, 1694-1697.
